87 related articles for article (PubMed ID: 1762057)
1. SC-46275: a potent, long-acting gastric antisecretory prostaglandin with low oral bioavailability in the dog.
Perkins WE; Burton EG; Tsai BS; Collins PW; Casler JJ; Gasiecki AF; Bauer RF; Jones PH; Gaginella TS
J Pharmacol Exp Ther; 1991 Dec; 259(3):1004-7. PubMed ID: 1762057
[TBL] [Abstract][Full Text] [Related]
2. Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.
Tsai BS; Keith RH; Perkins WE; Walsh RE; Anglin CP; Collins PW; Gasiecki AW; Bauer RF; Jones PH; Gaginella TS
J Pharmacol Exp Ther; 1995 Oct; 275(1):368-73. PubMed ID: 7562572
[TBL] [Abstract][Full Text] [Related]
3. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
[TBL] [Abstract][Full Text] [Related]
4. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
[TBL] [Abstract][Full Text] [Related]
5. Gastric antisecretory and cytoprotective activity of MDL 646, a 16-methyl-16-methoxy prostaglandin E1 analog in man.
Petrillo M; Lazzaroni M; Fuccella L; Sassella D; Bianchi Porro G
Hepatogastroenterology; 1987 Jun; 34(3):117-9. PubMed ID: 3610017
[TBL] [Abstract][Full Text] [Related]
6. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
[TBL] [Abstract][Full Text] [Related]
7. Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
Perkins WE; Bianchi RG; Tremont SJ; Collins PW; Casler JJ; Fenton RL; Wagner GM; McGrath MP; Stolzenbach JC; Kowalski DL
J Pharmacol Exp Ther; 1994 Apr; 269(1):151-6. PubMed ID: 8169819
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of canine gastric secretion by the prostanoid Ro 22-6923.
Gaginella TS; Bertko RJ; Müller RK; Gallo-Torres H; Sullivan AC
Dig Dis Sci; 1985 Apr; 30(4):340-5. PubMed ID: 3979240
[TBL] [Abstract][Full Text] [Related]
9. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
[TBL] [Abstract][Full Text] [Related]
10. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
11. Current status of acid pump antagonists (reversible PPIs).
Wurst W; Hartmann M
Yale J Biol Med; 1996; 69(3):233-43. PubMed ID: 9165692
[TBL] [Abstract][Full Text] [Related]
12. An alprostadil analogue and human gastric secretion. A double-blind placebo-controlled study of the effects of a tablet and lyovial formulation.
Müller P; Dammann HG; Simon B
Arzneimittelforschung; 1987 Aug; 37(8):972-4. PubMed ID: 3675697
[TBL] [Abstract][Full Text] [Related]
13. Effect of trimoprostil on gastric secretion in man.
Ishimori A; Kawamura T; Koizumi F
Arzneimittelforschung; 1988 Jun; 38(6):833-9. PubMed ID: 3140824
[TBL] [Abstract][Full Text] [Related]
14. An alprostadil analogue and human gastric secretion. A double-blind placebo-controlled study of the effects of a capsule and tablet formulation.
Müller P; Dammann HG; Leucht U; Simon B
Arzneimittelforschung; 1989 Jul; 39(7):809-11. PubMed ID: 2783184
[TBL] [Abstract][Full Text] [Related]
15. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of gastric acid secretion by omeprazole in the dog and rat.
Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G
Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713
[TBL] [Abstract][Full Text] [Related]
17. Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid.
Tsai BS; Kessler LK; Stolzenbach J; Schoenhard G; Bauer RF
Dig Dis Sci; 1991 May; 36(5):588-93. PubMed ID: 1850690
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of acid secretion and gastric lesions in rats by the prostanoid Ro 22-6923.
Gaginella TS; Müller RK; Witt CG; Rosen P; Holland GW; Gallo-Torres H; Sullivan AC
J Pharmacol Exp Ther; 1985 Jan; 232(1):202-7. PubMed ID: 2578188
[TBL] [Abstract][Full Text] [Related]
20. Effect of the synthetic prostanoid Ro 22-6923 on gastric secretion and blood flow in Heidenhain pouch dogs.
Gaginella TS; Bertko RJ; Müller RK; Gallo-Torres H; Sullivan AC
J Pharmacol Exp Ther; 1985 Jan; 232(1):208-13. PubMed ID: 3917506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
